PlainPharmaWatch

CMS Open Payments · Tool

Gyrus ACMI, Inc. vs Intera Oncology, Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Gyrus ACMI, Inc. has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 5,269, versus 720 for the other company. Its single largest recorded recipient represents 0.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Gyrus ACMI, Inc.
HHI 5,269 · top recipient 0.7%
Ranked #318 of 1,838 companies by HHI
Intera Oncology, Inc
HHI 720 · top recipient 0.2%
Ranked #1,162 of 1,838 companies by HHI

Payment Overview

Company A

Gyrus ACMI, Inc.

Total Payments
$738.6K
% of Industry
0.0%
Transactions
142
Avg per Transaction
$5.2K
Recipients
91
Avg per Recipient
$8.1K
Payment Types
7
Top Payment Type
Space Rental or Facility Fees
Total Payments
$739.7K
% of Industry
0.0%
Transactions
314
Avg per Transaction
$2.4K
Recipients
313
Avg per Recipient
$2.4K
Payment Types
2
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Gyrus ACMI, Inc. vs Intera Oncology, Inc - total reported payments in CMS Open Payments PY2024

Intera Oncology, Inc$739.7KGyrus ACMI, Inc.$738.6K

Payment Types Breakdown

Gyrus ACMI, Inc.

Space Rental or Facility Fees $119.3K

16.1%

Education $99.2K

13.4%

Consulting Fee $50.9K

6.9%

Debt Forgiveness $20.6K

2.8%

Royalty or License $11.0K

1.5%

Travel and Lodging $2.7K

0.4%

Intera Oncology, Inc

Consulting Fee $59.1K

8.0%

Food and Beverage $31.9K

4.3%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Gyrus ACMI, Inc.

  1. 1

    Tufts Medical Center

    $218,475.70 · 7 txns

  2. 2

    Newark Beth Israel Medical Center

    $19,560.00 · 1 txns

  3. 3

    MOMEN WAHIDI

    $16,096.98 · 16 txns

  4. 4

    ALEXANDER C CHEN

    $13,872.65 · 14 txns

  5. 5

    ROBERT GOLDENBERG

    $8,780.46 · 4 txns

Intera Oncology, Inc

  1. 1

    LOUISE CONNELL

    $18,194.33 · 10 txns

  2. 2

    DEVIKA RAO

    $10,999.99 · 8 txns

  3. 3

    JASON ALFRED CASTELLANOS

    $6,375.00 · 3 txns

  4. 4

    CORNELIUS THIELS

    $5,500.00 · 2 txns

  5. 5

    NANCY KEMENY

    $5,250.00 · 6 txns

Summary Comparison

Metric Gyrus ACMI, Inc. Intera Oncology, Inc
Total Payments $738.6K $739.7K
% of Industry Total 0.0% 0.0%
Transaction Count 142 314
Avg per Transaction $5.2K $2.4K
Recipient Count 91 313
Avg per Recipient $8.1K $2.4K
Payment Type Count 7 2
Top Payment Type Space Rental or Facility Fees Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.